Many patients endure hours-long infusions because antibody doses can exceed 100 milliliters, far beyond subcutaneous limits ...

The company’s first-in-class and potential best-in-class therapeutics promise to be both effective and organ-protective and ...

As we head into the 2026, let's take a look at biotech licensing deals and M&As that were inked in December 2025.

Backers claim the tests can predict a child’s risk of autism using a strand of hair or a mother’s blood, but critics say they ...

Genmab continues to advance several late-stage investigational antibody medicines across solid tumors and hematological malignancies and is investing in state-of-the-art digital and AI-driven ...

Elanco Animal Health (ELAN) is back in focus after securing USDA approval for Befrena, a new anti IL31 monoclonal antibody for canine dermatitis, along with updates to its Zenrelia label and ongoing ...

Experts discuss the critical challenges in accessing innovative treatments for relapsed refractory multiple myeloma, ...

From hair regrowth to safe pregnancy chemotherapy and new targeted therapies, these top five breast cancer stories of 2025 ...

One day, probably in the next year or two, a company will claim it has put the first artificial-intelligence-designed ...

CR-001 IND cleared by U.S. FDA; Phase 1/2 ASCEND global clinical trial to evaluate CR-001 in first-line and previously ...

Jazz’s Ziihera and BeOne’s Tevimbra plus chemotherapy led to what Truist Securities dubbed one of the strongest overall ...

A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly ...